Hively Brad, a director at Oncology Institute, Inc. ($TOI), made two open market purchases totaling nearly $57,000 in the last year, with the latest on March 26, 2025. These rank 2,865th among nearly 5,000 insiders averaging 1.5 million per buyer over 3.3 transactions. He also sold shares four times for 5.8 million, most recently on December 15, 2025, ranking 1,736th among over 11,700 insiders averaging 8.6 million over 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | S | Common Stock | 13333 | $3.77 | 683,721.0000 | 99,303,511 | 1.91% | 0.01% |
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | A | Common Stock | 41667 | $0.00 | 664,647.0000 | 99,303,511 | 6.69% | 0.04% |
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | A | Common Stock | 32407 | $0.00 | 697,054.0000 | 99,303,511 | 4.88% | 0.03% |
| Aug. 19, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | S | Common stock | 20221 | $4.06 | 622,980.0000 | 95,013,596 | 3.14% | 0.02% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Common Stock | 946460 | $0.85 | 2,579,638.0000 | 90,661,800 | 57.95% | 1.04% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | S | Common Stock | 1867605 | $2.87 | 712,033.0000 | 90,661,800 | 72.40% | 2.06% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | S | Common Stock | 108532 | $2.87 | 603,501.0000 | 90,661,800 | 15.24% | 0.12% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 684528 | $0.00 | 0.0000 | 90,661,800 | 0.00% | 0.76% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 105320 | $0.00 | 0.0000 | 90,661,800 | 0.00% | 0.12% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 131297 | $0.00 | 0.0000 | 90,661,800 | 0.00% | 0.14% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 946460 | $0.00 | 0.0000 | 90,661,800 | 0.00% | 1.04% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Common Stock | 105320 | $0.48 | 1,501,881.0000 | 90,661,800 | 7.54% | 0.12% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Common Stock | 684528 | $0.85 | 1,396,561.0000 | 90,661,800 | 96.14% | 0.76% |
| June 3, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Common Stock | 131297 | $1.87 | 1,633,178.0000 | 90,661,800 | 8.74% | 0.14% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | P | Common Warrant | 22640 | $0.13 | 22,640.0000 | 77,470,886 | 9999.99% | 0.03% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | P | Common Stock | 45280 | $1.04 | 712,033.0000 | 77,470,886 | 6.79% | 0.06% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | P | Common Warrant | 4528 | $0.13 | 4,528.0000 | 77,470,886 | 9999.99% | 0.01% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | P | Common Stock | 9056 | $1.04 | 675,809.0000 | 77,470,886 | 1.36% | 0.01% |
| Nov. 26, 2024 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | P | Common stock | 250000 | $0.17 | 616,753.0000 | 77,292,849 | 68.17% | 0.32% |
| Dec. 2, 2024 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | P | Common stock | 50000 | $0.15 | 666,753.0000 | 77,292,849 | 8.11% | 0.06% |
| Nov. 12, 2024 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | J | Common stock | 353450 | $0.00 | 366,753.0000 | 77,292,849 | 49.08% | 0.46% |
| Nov. 22, 2024 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | A | Common stock | 44000 | $0.00 | 720,203.0000 | 77,292,849 | 6.51% | 0.06% |
| June 17, 2024 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | D | Common Stock | 18121 | $0.46 | 676,203.0000 | 76,046,694 | 2.61% | 0.02% |
| May 22, 2024 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | D | Common Stock | 19526 | $0.58 | 694,324.0000 | 76,046,694 | 2.74% | 0.03% |
| Dec. 26, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | A | Common stock | 42652 | $0.00 | 713,850.0000 | 73,265,621 | 6.35% | 0.06% |
| Nov. 21, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | D | Common stock | 25867 | $2.19 | 671,198.0000 | 73,265,621 | 3.71% | 0.04% |
| Nov. 17, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | S | Common stock | 25000 | $2.24 | 697,065.0000 | 73,265,621 | 3.46% | 0.03% |
| Nov. 17, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 25000 | $0.00 | 1,745,431.0000 | 73,265,621 | 1.41% | 0.03% |
| Nov. 17, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Common stock | 25000 | $0.85 | 722,065.0000 | 73,265,621 | 3.59% | 0.03% |
| Nov. 13, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 47000 | $0.00 | 1,770,431.0000 | 73,265,621 | 2.59% | 0.06% |
| Nov. 13, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | M | Common stock | 47000 | $0.85 | 771,182.0000 | 73,265,621 | 6.49% | 0.06% |
| Nov. 13, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | S | Common stock | 47000 | $2.52 | 724,182.0000 | 73,265,621 | 6.09% | 0.06% |
| Nov. 14, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Director | D | Common stock | 27117 | $2.39 | 697,065.0000 | 73,265,621 | 3.74% | 0.04% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Chief Executive Officer | A | Common stock | 168512 | $0.00 | 724,182.0000 | 73,265,621 | 30.33% | 0.23% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | Hively Brad | Chief Executive Officer | A | Non-Qualified Stock Option (right to buy) | 421280 | $0.00 | 421,280.0000 | 73,265,621 | 9999.99% | 0.58% |